文献速递放疗物理与技术消化道肿瘤放疗姑息放疗与转移瘤

质子FLASH放疗系统的设计、实现与在体验证

Design, Implementation, and in Vivo Validation of a Novel Proton FLASH Radiation Therapy System.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2020-01-01

本研究设计并描述了使用双散射质子与CT引导的FLASH质子放疗系统,在KPC胰腺癌小鼠模型中验证其对正常组织的保护作用。系统剂量率验证为FLASH 78±9 Gy/s、标准0.9±0.08 Gy/s。全腹15 Gy FLASH质子放疗显著减少肠隐窝增殖细胞丢失,局部肠道18 Gy照射减少纤维化,但未在MH641905胰腺癌移植瘤中显示肿瘤保护作用。

要点

  • FLASH质子放疗系统剂量率验证为78±9 Gy/s,标准为0.9±0.08 Gy/s。
  • 全腹15 Gy FLASH质子放疗显著减少肠隐窝增殖细胞丢失。
  • 局部肠道18 Gy FLASH质子放疗减少纤维化至近基线水平。

核心结论

  • FLASH质子放疗可减少全腹和局部肠道照射后的急性细胞丢失和晚期纤维化,同时保持肿瘤生长抑制。

研究设计与样本

  • 研究使用双散射质子与CT引导的FLASH质子放疗系统,在KPC胰腺癌模型同源C57BL/6J小鼠中分析肠道纤维化和干细胞再增殖。

主要发现

  • FLASH和标准质子放疗的剂量率分别为78±9 Gy/s和0.9±0.08 Gy/s。
  • 全腹15 Gy FLASH质子放疗较标准质子放疗显著减少肠隐窝增殖细胞丢失。
  • 局部肠道18 Gy FLASH质子放疗较标准质子放疗减少肠道纤维化至近基线水平。
  • 12或18 Gy照射后FLASH质子放疗在MH641905胰腺癌移植瘤中未显示肿瘤保护作用。

临床怎么用

  • 该系统具有毫秒时间尺度束流控制和在线监测,可用于临床前FLASH质子放疗研究。
  • FLASH质子放疗在减少正常组织损伤的同时保持肿瘤控制,支持进一步临床转化研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Recent studies suggest that ultrahigh-dose-rate, "FLASH," electron radiation therapy (RT) decreases normal tissue damage while maintaining tumor response compared with conventional dose rate RT. Here, we describe a novel RT apparatus that delivers FLASH proton RT (PRT) using double scattered protons with computed tomography guidance and provide the first report of proton FLASH RT-mediated normal tissue radioprotection. METHODS AND MATERIALS: Absolute dose was measured at multiple depths in solid water and validated against an absolute integral charge measurement using a Faraday cup. Real-time dose rate was obtained using a NaI detector to measure prompt gamma rays. The effect of FLASH versus standard dose rate PRT on tumors and normal tissues was measured using pancreatic flank tumors (MH641905) derived from the KPC autochthonous PanCa model in syngeneic C57BL/6J mice with analysis of fibrosis and stem cell repopulation in small intestine after abdominal irradiation. RESULTS: The double scattering and collimation apparatus was dosimetrically validated with dose rates of 78 ± 9 Gy per second and 0.9 ± 0.08 Gy per second for the FLASH and standard PRT. Whole abdominal FLASH PRT at 15 Gy significantly reduced the loss of proliferating cells in intestinal crypts compared with standard PRT. Studies with local intestinal irradiation at 18 Gy revealed a reduction to near baseline levels of intestinal fibrosis for FLASH-PRT compared with standard PRT. Despite this difference, FLASH-PRT did not demonstrate tumor radioprotection in MH641905 pancreatic cancer flank tumors after 12 or 18 Gy irradiation. CONCLUSIONS: We have designed and dosimetrically validated a FLASH-PRT system with accurate control of beam flux on a millisecond time scale and online monitoring of the integral and dose delivery time structure. Using this system, we found that FLASH-PRT decreases acute cell loss and late fibrosis after whole-abdomen and focal intestinal RT, whereas tumor growth inhibition is preserved between the 2 modalities.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Diffenderfer ES, Verginadis II, Kim MM, et al. Design, Implementation, and in Vivo Validation of a Novel Proton FLASH Radiation Therapy System. Int J Radiat Oncol Biol Phys. 2020. PMID: 31928642. doi:10.1016/j.ijrobp.2019.10.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。